Literature DB >> 20161090

Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Carlota Lopez Cara, Delia Preti, Mojgan Aghazadeh Tabrizi, Jan Balzarini, Ernest Hamel, Enrica Fabbri, Roberto Gambari.   

Abstract

Identification of novel and selective anticancer agents remains an important and challenging goal in pharmacological research. The indole nucleus, frequently encountered as a molecular fragment in natural products and pharmaceutically active compounds, was employed as the initial building block for the synthesis of a series of pyrazino[1,2-a]indoles 1a-k, variably substituted at the 6, 7, 8 and 9-positions. Compound 1e, bearing the methoxy group at the 8-position of the pyrazino[1,2-a]indole nucleus was identified as a novel potent antiproliferative agent against the human chronic myelogenous leukemia K562 cell line, but it was much less active against several other cancer cell lines. Comparison of positional isomers indicated that moving the methoxy group from the 8- to the 7- or 6-position, to furnish compounds 1f and 1g, respectively, yielded inactive compounds. The analysis of structure-activity relationships observed in the series of investigated compounds may represent the basis for the design of more active molecules.

Entities:  

Year:  2009        PMID: 20161090      PMCID: PMC2744412          DOI: 10.2174/157018009788452519

Source DB:  PubMed          Journal:  Lett Drug Des Discov        ISSN: 1570-1808            Impact factor:   1.150


  18 in total

Review 1.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

Review 2.  Synthesis and biological activity of new class of dioxygenated anticancer agents.

Authors:  Maria Dolors Pujol; Manel Romero; Isabel Sánchez
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-05

3.  Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallography.

Authors:  Marc Nazaré; David W Will; Hans Matter; Herman Schreuder; Kurt Ritter; Matthias Urmann; Melanie Essrich; Armin Bauer; Michael Wagner; Jörg Czech; Martin Lorenz; Volker Laux; Volkmar Wehner
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

4.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

5.  Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S.

Authors:  R Gambari; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

Review 7.  Ruthenium antimetastatic agents.

Authors:  Enzo Alessio; Giovanni Mestroni; Alberta Bergamo; Gianni Sava
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 8.  Novel anticancer agents in clinical development.

Authors:  Alex A Adjei; Eric K Rowinsky
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

9.  Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.

Authors:  Nalan Terzioglu; Richard M van Rijn; Remko A Bakker; Iwan J P De Esch; Rob Leurs
Journal:  Bioorg Med Chem Lett       Date:  2004-11-01       Impact factor: 2.823

Review 10.  Apoptosis in acute leukemia.

Authors:  Dezso Schuler; Béla Szende
Journal:  Leuk Res       Date:  2004-07       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.